View All ETFs

SURI

Simplify Propel Opportunities ETF

Spotlight Banner
as of 04/16/2025

NAV

$ 13.63

NAV Change

- $ 0.19 /1.37%

Price

$ 13.60

Price Change

- $ 0.21 /1.52%
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation.

The fund is sub-advised by Propel, which uses its deep scientific and commercial expertise in health sciences to identify the most promising health science investment opportunities.
Spotlight Banner

Documents

Fund Overview

As of 04/16/2025

Ticker Symbol
SURI
Gross Expense Ratio
2.79%
Net Expense Ratio
2.54%
CUSIP
82889N624
Total Assets
$59,424,862.31
Shares Outstanding
4,360,001
Distribution Rate as of 03/31/2025 Distribution rate calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution rate.
Distribution Rate Close
Distribution rate calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution rate.
17.72%
Distribution Frequency
Quarterly
30-Day SEC Yield (Subsidized) as of 03/31/2025 SEC 30-day Yield is available once fund has a full quarter of performance.
SEC 30-Day Yield Close
SEC 30-day Yield is available once fund has a full quarter of performance.
3.44%
30-Day SEC Yield (Unsubsidized) as of 03/31/2025
3.17%
Options Available
No
Inception Date
02/07/2023
Premium/Discount (%) as of 04/16/2025
-0.22%
NAV Per Share as of 04/16/2025
$13.63
Market Price as of 04/16/2025
$13.60
30-Day Median Bid-Ask Spread
1.07%
Bid/Ask
$13.30/$13.92
Midpoint Price
$13.61
Volume
491
NAV Symbol
SURI.NV
IOPV Symbol
SURI.IV
Shares Out. Symbol
SURI.SO
Schedule K-1
No
 
The Distribution Rate is the annual rate an investor would receive if the most recently declared distribution, which includes option income, remained the same going forward. The Distribution Rate is calculated by multiplying an ETF’s Distribution per Share by twelve (12), and dividing the resulting amount by the ETF’s most recent NAV. The Distribution Rate represents a single distribution from the ETF and does not represent its total return. The distribution rate may contain return of capital but an estimate cannot be provided at this time. Please refer to the 19a-1 notices for additional details regarding the distributions’ composition once they become available.

Management Fees

This table describes the fees and expenses that you may pay if you buy, sell, and hold shares of the Fund. Investors purchasing or selling shares of the Fund in the secondary market may be subject to costs (including customary brokerage commissions) charged by their broker. The fee table located in the prospectus and updates in prospectus supplements prevail.

Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment)
Management Fees12.75%
Distribution and Service (12b-1) Fees0.00%
Other Expenses0.00%
Acquired Fund Fees and Expenses20.04%
Total Annual Fund Operating Expenses2.79%
Fee Waiver3(0.25)%
Total Annual Fund Operating Expenses After Fee Waiver2.54%

1. Estimated for the Fund’s current fiscal year. The Fund has agreed to pay the adviser as compensation under a management agreement a monthly advisory fee (as a percentage of daily net assets) computed at the annual rate of 2.75% on assets up to$1 billion; 2.50% on assets over $1 billion and less than $5 billion; 2.00% on assets over $5 billion and less than $10 billion; and 1.00% on assets over $10 billion.

2. Acquired Fund Fees and Expenses are the indirect costs of investing in other investment companies. The operating expenses in this fee table will not correlate to the expense ratio in the Fund’s financial highlights because the financial statements include only the direct operating expenses incurred by the Fund.

3. The adviser and sub-adviser have each agreed to waive its respective advisory and sub-advisory fee by 0.25% on an annualized basis through October 31, 2025.

Fund Performance (Total Return)

As of 03/31/2025 03/31/2025

Monthly Quarterly
Cumulative 1 Month 3 Month 6 Month YTD 1 Year Since Inception
NAV -6.53% 0.70% -29.33% 0.70% -28.52% -13.52%
Market Price -3.95% 4.24% -30.10% 4.24% -28.61% -12.21%
Annualized 1 Year 3 Year Since Inception
NAV -28.52% — -6.55%
Market Price -28.61% — -5.91%
Cumulative 1 Year Since Inception
NAV -28.52% -13.52%
Market Price -28.61% -12.21%
Annualized 1 Year 3 Year 5 Year Since Inception
NAV -28.52% — — -6.55%
Market Price -28.61% — — -5.91%
The performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment returns and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance data for the most recent month-end is available above.

NAV: The dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding. Calculated at the end of each business day.

Market Price: The current price at which shares are bought and sold. Market returns are based upon the last trade price.

Historical Premium/Discount

Calendar Year 2024 1st Quarter of 2025
Days Traded at Premium
138
33
Days Traded at Discount
114
27
The above frequency distribution chart presents information about the difference between the daily market price for shares of the Fund and the Fund's reported Net Asset Value. The amount that the Fund's market price is above the reported NAV is called the premium. The amount that the Fund's market price is below the reported NAV is called the discount. The market price is determined using the midpoint between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund's NAV is calculated (usually 4:00 p.m. EST). The horizontal axis of the chart shows the premium or discount expressed in basis points. The vertical axis indicates the number of trading days in the period covered by the chart. Each bar in the chart shows the number of trading days in which the Fund traded within the premium/discount range indicated.

Portfolio Holdings

As of 04/16/2025

Holdings - All ETFs
Ticker Name Quantity Weight
TELSAT TELESAT CDA / TE 5.625 06DEC26 144A 2,700,000 2.75%
TELSAT TELESAT CDA / TELE 6.5 15OCT27 144A 6,124,000 4.28%
- CONTRA CHINOOK THERAPE + NPV 25,000 0.06%
ABEO ABEONA THERAPEUTICS INC USD 0.01 458,584 3.74%
ACHV ACHIEVE LIFE SCIENCES INC USD 0.001 217,845 0.77%
AKRO AKERO THERAPEUTICS INC USD 0.0001 145,609 9.17%
APLT APPLIED THERAPEUTICS INC USD 0.0001 4,487,505 2.29%
ATHA ATHIRA PHARMA INC USD 0.0001 1,492,792 0.58%
CMPX COMPASS THERAPEUTICS INC USD 0.0001 720,000 2.06%
DCTH DELCATH SYS INC USD 0.01 117,000 2.27%
EIGRQ EIGER BIOPHARMACEUTICALS USD 0.0001 90,000 0.71%
MAAT MAAT PHARMA SACA EUR 0.1 149,803 1.77%
MDGL MADRIGAL PHARMACEUTICALS USD 0.0001 16,294 8.44%
MIST MILESTONE PHARMACEUTICALS INC NPV 850,000 1.17%
PAGP PLAINS GP HLDGS L P 1,272,360 40.06%
PHAT PHATHOM PHARMACEUTICALS USD 0.0001 681,935 4.85%
RNA AVIDITY BIOSCIENCES INC USD 0.0001 125,000 5.42%
SNDX SYNDAX PHARMACEUTICALS I USD 0.0001 120,000 2.23%
TCRX TSCAN THERAPEUTICS INC USD 0.0001 1,046,916 2.29%
ZVRA ZEVRA THERAPEUTICS INC USD 0.0001 120,000 1.42%
- EURO 6,197 0.01%
- Estimated Cash 2,164,868 3.64%

Holdings are subject to change without notice.

Recent Distributions

Ex-Dividend Date Record Date Payable Date Total Distribution
N/A
$0.68000
$0.68000
$0.68000
$1.25000
View Distribution History
S19(a) Notices Data in the s19 reports should not be relied upon to estimate the tax classification of distributions. They are rough point-in-time estimates that do not line up with the fund's fiscal year end and are thus not reflective of the tax information investors should expect. S19 reports are posted for regulatory requirements only.
S19(a) Notices Close
Data in the s19 reports should not be relied upon to estimate the tax classification of distributions. They are rough point-in-time estimates that do not line up with the fund's fiscal year end and are thus not reflective of the tax information investors should expect. S19 reports are posted for regulatory requirements only.

Register for Simplify's Investor Hub

  • In-depth case studies provide valuable insights into practical portfolio problems and their solutions
  • Simplify curated model portfolios that show investors how to incorporate alternatives into their portfolio
  • Stay up-to-date with our latest thoughts on markets via our weekly market commentaries
Create Your Account
Register Info
Contact Us